ORMP · NASDAQ · Biotechnology

Oramed Pharmaceuticals (ORMP)

Develops oral formulations for insulin and other therapeutic proteins.

$4.72
vs last close−0.03 (−0.63%)

Dividend yield
Next ex-date
Annual dividend
Schedule

One payment since Jan 2026

Ex-dateRecordPaidAmountNote
Jan 16, 2026Jan 16, 2026Jan 26, 2026$0.25special dividend